Thursday, July 26, 2012

On The Road Again.

This coming Sunday through Tuesday, the folks at Roche are holding their fourth annual Social Media Summit - a gathering of diabetes advocates (30, or so?) who are invited to Roche's home base in Indianapolis for a couple days of discussion, feedback, brainstorming, and other whatnot. I say "other whatnot", because I've never been invited to one before, so I therefore don't have any first-hand knowledge of what goes on.... yet...

I'm honored to say that this year I was invited to attend, and so I'll be hopping on a plane Sunday morning to go talk diabetes for 48 hours. I've seen the list of folks going, and I'm excited about who will be there and the discussions we'll have!

As with summits like the ones Medtronic and Lilly put on earlier this year, Roche will be paying for my travel, hotel, and food expenses while I'm there for the summit. As a heads up, the AADE annual meeting thing (also in Indianapolis) begins the day after the Roche event concludes, so you may see that some DOC folks will be there for a whole week. All of this advocacy has really drained my vacation days at work, so unfortunately I won't be staying in town for that. (I should also point out that going to AADE is not part of the Roche summit experience [or what Roche is covering the expenses for] - it just happens that they're back-to-back in the same city.)

If there is something you'd like brought up to the folks at Roche while we're there, please leave your thoughts in the comments, and I'll do my best to make sure it's addressed!

P.S. If you're on Twitter and want to follow along, the hashtag for the summit is #dsummit12.

3 comments:

  1. So so so glad that you should be one of the first people I see :)

    ReplyDelete
  2. very exciting! have a safe one.

    ReplyDelete
  3. Kim, I have a few questions. Sorry if this is a little long.

    1) How's Glooko going? Any plans to change anything, or bring it to an additional (Android?) Platform?

    2) An FDA panel recommended their new drug, Lucentis (brand name) yesterday. It's for treating Diabetic Macular Edema. Anything else they can tell us about this drug?

    3) Roche announced earnings yesterday. While earnings were down a bit, they were still pretty good. I'm interested in knowing how much of their research & development budget is spent on diabetes R&D? They won't give you numbers (or francs, since they're Swiss), but maybe a percentage? And how is that budgeted? Per year, on a multi-year basis, etc.? How are those decisions made?

    Okay, that's more than a few. Thanks for hearing me out. Enjoy the trip!

    ReplyDelete